When it comes to favourite pharmas, one company is a clear standout according to this patient cohort which says industry's overall corporate reputation has improved... except in one crucial area
Minister deftly sidesteps questions about growing speculation he is the Labor Party's "leader-in-waiting" when Anthony Albanese's time as PM comes to an end
The BMS Patient & Parliament Summit will be held in Canberra today with urgent action needed for patients who fear they won't survive the wait for treatment
New figures released by the Department of Health shows more than one million women have accessed newly PBS listed medicines since March 2025
Jobs have been cut following a recent field force review with changes made to ensure the company's customer coverage model reflects an evolving market
High-flyer has been promoted to Country Lead, taking responsibility for heading the company's innovative medicines business in Australia
A previously prescription-only drug has hit the shelves as a pharmacy drug, with the hope it will increase awareness of the ability to treat symptoms
The agenda for the November PBAC meeting has been updated with one company rejected in July making quick work of trying again
A new asthma treatment set to be considered for PBS funding at the PBAC's intracycle meeting this month has been approved for use in Australia
Despite the overall trend of tech dominance in the US, two pharmaceutical companies have broken into TIME’s Top 10 list of America’s Best Companies for 2026.
Two senior pharma executives - one a former Aussie GM - have called out perfect work-life balance as an unrealistic expectation placed on the industry
Medicines Australia has outlined an ambitious plan for the Government to double its spending on innovative medicines
A breakthrough drug for pancreatic cancer was given a standing ovation at ASCO this year but for Australian patients there's likely a long wait ahead
Stepping up from a Business Unit Director role, this executive has packed her bags and made the move to Bulgaria, to take on the position of General Manager at a Big Pharma
With another jurisdiction revoking approval, it's not looking good for a drug that has been linked to eight deaths overseas that is being reviewed by the TGA.
The ACCC has given the go-ahead for the merger of a Johnson & Johnson spin-out with another mega company... but on one condition
Companies have been urged to apply the "PUB Test" to upcoming initiatives designed to engage HCPs - before they go to market - otherwise they risk missing the mark
Once-daily pill, the first treatment of its kind to be registered in Australia for a debilitating condition, marks an 'important milestone' for patients
From banning discrimination in genetic testing to ground-breaking infectious disease discoveries, this year's Eureka prizes saw well-known names take home gongs
General Manager announces a “fresh start” for the pharma in a slick new office space with the latest technology and design to enable flexible-based working plus connection with patients and partners
The 22nd PRIME Awards have attracted entries from more organisations than ever before making this one of the strongest and most competitive fields in the event's history
Several years after leaving the industry body, this company has returned as a Class 1 member, saying the innovative medicines sector is strongest when it works together
There can be clear disagreements over the price which should be paid for a drug, but some features of the reimbursement system mean neither side really knows what the other expects
